Morioka Shinichiro, Tsuzuki Shinya, Gu Yoshiaki, Fujitomo Yumiko, Soeda Hiroshi, Nakahama Chikara, Hasegawa Naoki, Maesaki Shigefumi, Maeda Masayuki, Matsumoto Tetsuya, Miyairi Isao, Ohmagari Norio
The Research Committee of the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases on Antimicrobial Stewardship in Clinics, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
The Research Committee of the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases on Antimicrobial Stewardship in Clinics, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
J Infect Chemother. 2025 Feb;31(2):102532. doi: 10.1016/j.jiac.2024.09.021. Epub 2024 Oct 2.
A nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases in 2020 provided insights into antimicrobial prescription practices among clinic doctors. This study aimed to investigate factors influencing changes in antimicrobial prescriptions post-implementation of the National Action Plan on Antimicrobial Resistance (NAPAR) and doctors' inclination to prescribe antimicrobials for common cold cases.
In September 2020, randomly selected questionnaires were distributed to 3000 community-based medical clinics in Japan. The primary objective was to assess the reduction in antimicrobial prescriptions post-NAPAR implementation. Multivariate linear regression analysis was employed to identify associated factors.
Analysis of 632 responses (response rate: 21.1 %) revealed determinants of decreased antimicrobial prescriptions, including familiarity with the Guide to Antimicrobial Stewardship (β = .482, t = 3.177, p = 0.002) and awareness of NAPAR (β = .270, t = 2.301, p = 0.022).
Interventions such as the Guide to Antimicrobial Stewardship may have contributed to the reduction in antimicrobial prescriptions among Japanese physicians. However, targeted strategies are needed to address high-prescription groups. Enhancing awareness and education on appropriate antimicrobial use should be integral components of future initiatives to combat antimicrobial resistance effectively.
日本化疗学会和日本传染病协会在2020年进行的一项全国性调查,为了解临床医生的抗菌药物处方行为提供了见解。本研究旨在调查影响《国家抗菌药物耐药性行动计划》(NAPAR)实施后抗菌药物处方变化的因素,以及医生为普通感冒病例开具抗菌药物的倾向。
2020年9月,向日本3000家社区诊所随机发放问卷。主要目的是评估NAPAR实施后抗菌药物处方的减少情况。采用多元线性回归分析来确定相关因素。
对632份回复(回复率:21.1%)的分析揭示了抗菌药物处方减少的决定因素,包括对抗菌药物管理指南的熟悉程度(β = 0.482,t = 3.177,p = 0.002)和对NAPAR的知晓度(β = 0.270,t = 2.301,p = 0.022)。
抗菌药物管理指南等干预措施可能有助于减少日本医生的抗菌药物处方。然而,需要有针对性的策略来应对高处方群体。加强对抗菌药物合理使用的认识和教育应成为未来有效抗击抗菌药物耐药性举措的组成部分。